Overview

Skip to main content

Overview

Event Details

Glaukos’ iDose TR FDA Approval Conference Call

December 14, 2023 8:30 AM ET

Webcast (opens in new window)

Presentation (opens in new window)

Contact Us

Glaukos Corporation
One Glaukos Way
Aliso Viejo, CA 92656

949-481-0510
Send Email

Quick Links

SEC Filings
Investor FAQs
Information Request Form
Annual Report
Proxy Statement
Sustainability Report

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Glaukos, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Glaukos to send you the requested Investor Email Alert updates.

* Required

Email Address *

Investor Alert Options

Investor Alert Options *

News
Quarterly Reports
Annual Reports
SEC Filings
End of Day Stock Quote
Events & Presentations

Unsubscribe

Email Alert Sign Up Confirmation

Privacy Policy
Terms of Use

© Glaukos Corporation. Glaukos and iLink™ are registered trademarks of Glaukos Corporation. KXL® is a registered trademark and VibeX Rapid® is a trademark of Avedro, a Glaukos company.

Powered By Q4 Inc. 5.147.1.2 (opens in new window)